Walleye Capital’s Kailera Therapeutics KLRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.76M Buy
+416,853
New +$7.04M ﹤0.01% 1945

Other funds holding KLRA

Walleye Capital's KLRA Position: Q3 2026 in Review

Walleye Capital opened a new position in Kailera Therapeutics (KLRA) in Q3 2026: 416,853 shares worth $4.76M. The stake represents ﹤0.01% of the portfolio and ranks #1945 among its holdings.

129 funds tracked by Wall St. Rank hold KLRA as of Q3 2026.

  • Walleye Capital held 416,853 shares of Kailera Therapeutics worth $4.76M as of Q3 2026.
  • Kailera Therapeutics was a new Walleye Capital position in Q3 2026.
  • Kailera Therapeutics made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #1945 holding.
  • 129 funds tracked by Wall St. Rank held Kailera Therapeutics as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.